Literature DB >> 23362654

Clinical factors associated with left ventricular ejection fraction disparity in patients with left ventricular dysfunction undergoing multimodality imaging.

Adnan Khalid1, Salman K Bhatti, Mohammad Al-Amoodi, John A House, Taiyeb M Khumri, James H O'Keefe, Michael L Main.   

Abstract

Drug and device therapy for heart failure is increasingly determined based on left ventricular ejection fraction. Significant disparity frequently exists between echocardiographic and nuclear scintigraphic techniques, even when testing is performed nearly simultaneously in clinically stable patients. In 119 patients with left ventricular dysfunction who underwent both echocardiography and stress testing with nuclear imaging within seven days (but with significant disparity in reported left ventricular ejection fraction), we identified four clinical variables which were associated with left ventricular ejection fraction difference. These clinical variables included atrial fibrillation, left ventricular hypertrophy, severe mitral regurgitation and paced rhythm.

Entities:  

Mesh:

Year:  2012        PMID: 23362654      PMCID: PMC6179602     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  8 in total

1.  Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

Authors:  N G Bellenger; M I Burgess; S G Ray; A Lahiri; A J Coats; J G Cleland; D J Pennell
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

2.  Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging.

Authors:  Siri Malm; Sigmund Frigstad; Einar Sagberg; Henrik Larsson; Terje Skjaerpe
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

3.  Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography.

Authors:  Rainer Hoffmann; Stephan von Bardeleben; Folkert ten Cate; Adrian C Borges; Jaroslaw Kasprzak; Christian Firschke; Stephane Lafitte; Nidal Al-Saadi; Stefanie Kuntz-Hehner; Marc Engelhardt; Harald Becher; Jean Louis Vanoverschelde
Journal:  Eur Heart J       Date:  2004-12-17       Impact factor: 29.983

Review 4.  ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  Sharon Ann Hunt
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

5.  Long-term effect of right ventricular pacing on myocardial perfusion and function.

Authors:  H F Tse; C P Lau
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

6.  Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.

Authors:  M St John Sutton; M A Pfeffer; L Moye; T Plappert; J L Rouleau; G Lamas; J Rouleau; J O Parker; M O Arnold; B Sussex; E Braunwald
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

7.  Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block.

Authors:  J H O'Keefe; T M Bateman; C S Barnhart
Journal:  J Am Coll Cardiol       Date:  1993-05       Impact factor: 24.094

8.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Authors:  Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell
Journal:  Am J Cardiol       Date:  2002-07-01       Impact factor: 2.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.